Sign in to view content

Assessment of Central Subfield Thickness Fluctuations and Impact on Vision in Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS)

Chirag D. Jhaveri, MD, FASRS

Video
Published 2021

Related

Impact of Race on Vision Outcomes in Ranibizumab-Treated Patients With Diabetic Macular Edema: A Meta-Analysis of 5 Clinical Trials
M. Ali Khan, MD, FACS, FASRS
Annual Meeting Talks
2021
Treatment Switch From Aflibercept to Ranibizumab Pre-filled Syringe in Canadian DME Patients in a Real-World Setting: The PRECISE Study
Michel R Giunta, MD
On Demand Cases, Courses, and Papers
2021
Impact of Race on Vision Outcomes in RanibizumabTreated Patients With Diabetic Macular Edema: A Meta-Analysis of 5 Clinical Trial
M. Ali Khan, MD, FACS, FASRS
Updates from the Field
2021

Category: AMD-Neovascular

See more